Uremic Toxin Removal With a New High Flux Cellulose Triacetate Membrane

2010-07-15 17:00:00 | BioPortfolio


Comparison of the uremic toxin removal by haemodialysis either with a low flux or a new high flux cellulose triacetate membrane


Comparison of the uremic toxin removal by haemodialysis either with a low flux or a new high flux cellulose triacetate membrane

Study Design

Allocation: Randomized, Control: Active Control, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment




Haemodialysis with either low or high flux membranes


University Hospital Ghent




University Hospital, Ghent

Results (where available)

View Results


Published on BioPortfolio: 2010-07-15T17:00:00-0400

Clinical Trials [297 Associated Clinical Trials listed on BioPortfolio]

Effect of Haemodialysis on the Efficacy of Antiplatelet Agents

The main purpose of our study is to investigate whether haemodialysis itself affects the efficacy of antiplatelet drugs and the effects of two different types of dialysis membranes (polysu...

Fatigue in Chronic Haemodialysis Patients: an Experience Sampling Method Study

To investigate the course and diurnal change of fatigue symptoms and haemodialysis related symptoms in chronic haemodialysis patients, its relation to haemodialysis treatment and the assoc...

Haemodialysis fMRI Salt Appetite Study

1. Assessing how the rapid removal of salt and water by haemodialysis alters regional brain activity (by measurement of the brain blood oxygen level-dependent (BOLD) signal using ...

European Trial of Free Light Chain Removal by Extended Haemodialysis in Cast Nephropathy

Hypothesis: Free light chain removal haemodialysis will increase the rate of renal recovery in patients with cast nephropathy, severe renal failure and de novo multiple myeloma. This stud...

Study of beta2-Microglobulin Removal by Standard Versus New High Cut-Off Haemodialysis Membrane

The purpose of this study is to determine whether a novel haemodialysis membrane, compared with the standard dialysis membrane, will increase the removal of beta2-microglobulin in chronic ...

PubMed Articles [13954 Associated PubMed Articles listed on BioPortfolio]

Can incremental haemodialysis reduce early mortality rates in patients starting maintenance haemodialysis?

Early mortality rates after the start of maintenance haemodialysis therapy are high. Compared with three-times weekly haemodialysis, incremental haemodialysis is associated with better preservation of...

Innovation in haemodialysis: Thinking 'out-of-the-box'. Avoiding central venous catheter in a maintenance haemodialysis patient following fracture of the arteriovenous access arm.

Independent Effect of Haemodialysis Session Frequency and Duration on Survival in Non-Indigenous Australians on Haemodialysis.

End-stage kidney disease (ESKD) patients have increased mortality compared to the general population. Haemodialysis (HD) of more frequent and of longer duration has been proposed to improve survival b...

Transcapillary Refilling Rate and Its Determinants during Haemodialysis with Standard and High Ultrafiltration Rates.

Achieving euvolaemia using ultrafiltration (UF) during haemodialysis (HD) without inducing haemodynamic instability presents a major clinical challenge. Transcapillary refill is a key factor in sustai...

Dialysis monitor and low-cost haemodialysis.

An experimental model of a hemodialysis monitor has been developed to perform ultrafiltration control, and urea and creatinine clearance tests. This model allowed us to develop an original device that...

Medical and Biotech [MESH] Definitions

Artificially produced membranes, such as semipermeable membranes used in artificial kidney dialysis (RENAL DIALYSIS), monomolecular and bimolecular membranes used as models to simulate biological CELL MEMBRANES. These membranes are also used in the process of GUIDED TISSUE REGENERATION.

Cell membranes associated with synapses. Both presynaptic and postsynaptic membranes are included along with their integral or tightly associated specializations for the release or reception of transmitters.

The adherence and merging of cell membranes, intracellular membranes, or artificial membranes to each other or to viruses, parasites, or interstitial particles through a variety of chemical and physical processes.

Chemical agents that increase the permeability of biological or artificial lipid membranes to specific ions. Most ionophores are relatively small organic molecules that act as mobile carriers within membranes or coalesce to form ion permeable channels across membranes. Many are antibiotics, and many act as uncoupling agents by short-circuiting the proton gradient across mitochondrial membranes.

An acidifying agent that has expectorant and diuretic effects. Also used in etching and batteries and as a flux in electroplating.

More From BioPortfolio on "Uremic Toxin Removal With a New High Flux Cellulose Triacetate Membrane"

Quick Search

Searches Linking to this Trial